Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 September 2025 | Story Anthony Mthembu | Photo Lunga Luthuli
Martin Nyaka
Martin Nyaka, Second Deputy Secretary General of the South African Union of Students (SAUS).

Martin Nyaka, Secretary General of the 2024-2025 Institutional Student Representative Council (ISRC) and Policy and Transformation Officer (CSRC) on the Bloemfontein Campus of the University of the Free State (UFS), has been elected as Second Deputy Secretary General (DSG) of the South African Union of Students (SAUS)

Nyaka was elected during the first leg of the SAUS conference, held in Gqeberha from 10-13 July 2025. His election is historic, as this is the first time the union has appointed a second DSG. In his new role, he joins the National Executive Council (NEC) alongside the SAUS President, Deputy President, Secretary General, Treasurer-General, and the First DSG.  

“It is a great honour for me to have represented the University of the Free State at this important platform, and I remain deeply grateful for the support and assistance I received from the institution throughout this journey,” said Nyaka. He will serve in this role until the next election in 2028. 

 

Anticipated impact

Nyaka explained that his decision to stand for election was influenced by challenges he and his SRC colleagues encountered when addressing certain student-related issues. He noted that some concerns, such as those linked with the National Student Financial Aid Scheme (NSFAS), can only be resolved at a national level. 

“This position places us in a better position to assist students and to ensure that our students are funded,” he said.  

In addition to his role as Second DSG, Nyaka also chairs the SAUS Monitoring and Evaluation portfolio, which oversees several sub-committees within the organisation.  

 

Lessons from leadership 

As his SRC term draws to a close, Nyaka reflected on the lessons he will carry into this new role. 

“Previously, as student leaders our mindset was very radical, and if ever things would not go our way, we would take to the streets,” he explained. “However, over this last term, the SRC resolved matters and reached agreements with management without protest. An important lesson I take with me is that radicalism is not always the answer. In an organisation like SAUS, we need to sit down and have discussions with stakeholders when there is a deadlock.”

Nyaka emphasised that what excites him most about the opportunity is the chance to work alongside student-leaders from across the country who are equally committed to making a meaningful impact.  

News Archive

Chakalaka can have side effects for these patients
2010-06-24

Chakalaka is a sauce many South Africans cannot imagine a meal without, but research at the Faculty of Health Sciences at the University of the Free State (UFS) has shown that it can have serious side effects and even compromise the treatment of leukaemia patients.

Prof. Vernon Louw from the Department of Internal Medicine at the Faculty says that tyrosine kinase inhibitors (TKIs) are a new group of drugs providing targeted therapy for chronic myeloid leukaemia (CML). It vastly contributes to the survival of patients, but it has side effects like vasodilatation. Research has shown that spices like chakalaka may aggravate vasodilatation (widening of veins) with patients on these drugs.

“These spices produce serious oedema (water retention) and headaches. We have found that discontinuing the intake of spices allows some patients to maintain therapeutic doses of TKIs.” Chakalaka contains mainly garlic and chilli.

CML represents up to 20% of all leukaemia patients in South Africa and up to 450 new cases are reported every year.

In the study symptoms of severe headache and oedema disappeared within days of discontinuing the use of chakalaka.

Prof. Louw says it is important for oncologists to ask their patients about their intake of spices and garlic when they are on TKIs. It is also advisable to enquire about the use of complementary alternative medicine as the interaction of these medicines in cancer treatment is not known.

Media Release

Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt@ufs.ac.za
23 June 2010
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept